<DOC>
	<DOCNO>NCT01172873</DOCNO>
	<brief_summary>This single site , open-label , feasibility study cognitive behavioral therapy exposure response prevention ( CBT/ERP ) add augmentation D-cycloserine ( DCS ) adolescent age 12-17 Obsessive Compulsive Disorder ( OCD ) partial non-responders first line treatment CBT pharmacotherapy .</brief_summary>
	<brief_title>D-Cycloserine Augmentation CBT With Exposure Response Prevention Adults Adolescents With OCD</brief_title>
	<detailed_description>The primary goal study examine feasibility efficacy DCS augmentation CBT/ERP end session . The main treatment outcome measure Yale-Brown Obsessive Compulsive Scale ( Y-BOCS ) . The secondary goal study investigate safety DCS adolescent OCD . 18 adolescent recruit study . Patients currently medication therapy OCD must stable least 12 week prior study . This study consist screen period contain 90-minute psycho-educational session treatment period 5 week . During treatment period , patient receive ten 60-minute CBT/ERP session hold twice weekly . At end session , patient receive 50 mg dose DCS . Following administration DCS , patient ask best ritualize remain Children 's Day Unit , observed report research team ritualization occur . At end study participation , participant offer 10 additional session twice-weekly ERP without DCS administration . All participant complete follow-up visit 10 week baseline . The main treatment outcome measure Yale-Brown Obsessive Compulsive Scale ( Y-BOCS ) . The secondary goal study investigate safety DCS adolescent OCD . Additionally , explore impact patient 's motivation change , parental pathology , family accommodation treatment progress outcome adolescent . Present data collect protocol show adolescent complete engaged treatment experienced benefit combination CBT/ERP DCS . However , unblinded study adolescent receive intensive form CBT/ERP close monitoring follow 2 hour administration DCS . The positive result may due specific way CBT/ERP deliver attention pay participant treatment session monitor period . We recruit 5 additional adolescent diagnose OCD serve control group participant . These individual history fail partial response least one trial Selective Serotonin Reuptake Inhibitor ( SSRI ) medication CBT/ERP . These participant also receive ten session twice weekly CBT/ERP deliver exactly previously protocol , without DCS administration . All control participant complete follow-up visit 10 week baseline . Due small number control participant , statistical analysis compare treatment group complete .</detailed_description>
	<mesh_term>Compulsive Personality Disorder</mesh_term>
	<mesh_term>Obsessive-Compulsive Disorder</mesh_term>
	<mesh_term>Compulsive Behavior</mesh_term>
	<mesh_term>Cycloserine</mesh_term>
	<criteria>Inclusion/Exclusion Criteria 1 . Patients must age 1217 time consent . 2 . Both patient parent must able speak understand English . 3 . Written inform assent patient consent parent . 4 . Ability willingness comply study treatment attend study assessment . 5 . Patients must physically healthy male nonpregnant female . Females childbearing potential must comply contraceptive restriction note protocol . 6 . Patients must fulfill Diagnostic Statistical Manual ( DSMIV ) criterion OCD , OCD must primary disorder CYBOCS score &gt; 16 7 . For patient attentiondeficit hyperactivity disorder ( ADHD ) , condition must stable 4 week present treatment prior screen . 8 . For patient receive treatment FDA approve Serotonin Reuptake Inhibitor ( SRI ) , medication dose must stable least 12 week prior enrollment . 9 . Patients fail respond either CBT/ERP treatment SRI medication ( evidence CYBOCS score &gt; 16 ) . 10 . Based history , patient unlikely require change medication course CBT/ERP + DCS treatment . 1 . Patients clinically significant abnormality laboratory parameter screen . 2 . Clinically significant metabolicendocrine , hematological , gastrointestinal disease , pulmonary disease ( example , severe asthma , uncontrolled diabetes mellitus ) . 3 . History schizophrenia psychotic disorder , history mental disorder present Axis I psychiatric disorder accord DSMIV criterion ( use Anxiety Disorders Interview Schedule ( ADISR ) assessment interview ) , except patient diagnosis ADHD and/or anxiety disorder secondary diagnosis . 4 . Patients history suggestive Pediatric Autoimmune Neuropsychiatric Disorders Associated Streptococcal infection ( PANDAS ) . i.e. , sudden onset exacerbation symptom temporally associate precede streptococcal infection first onset prior puberty . 5 . Patients receive formal psychotherapy , one deliver study , whether focus therapy OCD .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>OCD</keyword>
	<keyword>DCS</keyword>
	<keyword>D-cycloserine</keyword>
	<keyword>CBT</keyword>
	<keyword>E/RP</keyword>
	<keyword>exposure response prevention</keyword>
</DOC>